| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.9M | — | +39.1% |
| Cost of Revenue | $18.9M | — | -8.0% |
| Gross Profit | $8.0M | — | +742.9% |
| R&D Expense | $3.0M | — | -3.4% |
| SG&A Expense | $6.6M | — | +10.7% |
| Operating Income | -$1.6M | — | +84.6% |
| Pre-tax Income | -$1.1M | — | +89.4% |
| Income Tax | $430K | — | +481.1% |
| Net Income | -$1.6M | — | +81.6% |
| EPS (Basic) | -$0.03 | — | +85.0% |
| EPS (Diluted) | -$0.03 | — | +85.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.8M | -65.3% | +32.2% |
| Short-term Investments | $65.4M | — | — |
| Accounts Receivable | $32.0M | +19.2% | +40.0% |
| Inventory | $90.2M | +10.4% | +12.1% |
| Current Assets | $253.8M | +2.9% | +69.7% |
| Total Assets | $444.6M | +2.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.7M | — | -249.2% |
| Capital Expenditures | $1.4M | — | +169.0% |
| Investing Cash Flow | -$67.3M | — | -8457.3% |
| Financing Cash Flow | $8.0M | — | +16.2% |
| Free Cash Flow | -$13.1M | — | -238.6% |
| +33.3% |
| Current Liabilities | $97.9M | +8.1% | +30.1% |
| Total Liabilities | $107.6M | +8.6% | +23.3% |
| Stockholders' Equity | $274.9M | +0.6% | +48.6% |